Even though 50% of patients in both cohorts were already using ‘cardioprotective’ drugs prescribed for other reasons before initiating chemotherapy (mainly angiotensin-converting enzyme inhibitors, calcium channel blockers, beta-blockers for HTN), DR patients again had twice the likelihood of developing CTx. Here, ACE is linked to hypertensive disorder.